Jon M. Plexico
@Stonepine Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$158.248MTotal holdings38
Assets growth rate44.39%Assets growth rate (2-Q avg)15.67%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Stonepine Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Stonepine Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 158.248M in assets, with a quarterly growth rate of 44.39% and a 2-quarter average growth rate of 15.67%. The portfolio is managed by Jon M. Plexico, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
JAZZJazz Pharmaceuticals Plc Us Listed
| 3.88% | $6.128M 55,000 shares@ $111.41 avg price | New Position |
RPRXRoyalty Pharma Plc
| 3.79% | $5.997M 212,000 shares@ $28.29 avg price | New Position |
ZVRAZevra Therapeutics Inc
| 3.07% | $4.858M 700,000 shares@ $6.94 avg price | New Position |
VSTMVerastem Inc
| 2.48% | $3.918M 1.31M shares@ $2.99 avg price | New Position |
URGNUrogen Pharma Ltd
| 2.25% | $3.56M 280,345 shares@ $12.71 avg price | New Position |
ESTAEstablishment Labs Holdings
| 2.06% | $3.245M 75,000 shares@ $43.27 avg price | New Position |
DAWNDay One Biopharmaceuticals I
| 1.82% | $2.865M 205,675 shares@ $13.94 avg price | New Position |
INDVIndivior Plc
| 1.67% | $2.632M 270,000 shares@ $9.75 avg price | New Position |
ARQTArcutis Biotherapeutics Inc
| 0.52% | $822,650 88,457 shares@ $9.3 avg price | New Position |
FNAParagon 28 Inc
| 0.49% | $766,356 114,724 shares@ $6.68 avg price | New Position |